Autopsy report · NCT03716258

Characterizing Biomarkers of Early Parkinson's Disease Progression (TREG)

“COVID-19 Research Restrictions”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 2 years 4 months before it stopped.
• 16 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Oregon Health and Science University

Sponsor type

University, hospital or other

Conditions

Parkinson Disease; Movement Disorders

Participants

16

Sites

2

Countries

United States

Trials that died the same way

• Brief Intervention to Reduce Fear of Public Speaking
  “COVID-19 restrictions” (87% match in meaning)
• High-frequency vs. Low-frequency vs. Sham DMPFC-rTMS for Bulimia and Anorexia Nervosa
  “COVID-19 pandemic restrictions.” (85% match in meaning)
• RCT Evaluating Intranasal Fentanyl in the Pain Management of Children With Headaches
  “Covid restrictions” (78% match in meaning)
• How Muscle and Tendon Properties Contribute to Functional Change Prior to and Following Knee Replacement
  “Due to COVID-19 and research restrictions put in place by the university” (78% match in meaning)
• Impact of the Use of Zinc in the Prevention of Oral Mucositis in Pediatric Patients With Lymphoblastic Acute Leukemia.
  “Health restrictions due to the COVID-19 pandemic” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.